Mwanzo04K • FRA
add
Knight Therapeutics Inc
Bei iliyotangulia
€ 3.64
Bei za siku
€ 3.72 - € 3.72
Bei za mwaka
€ 3.40 - € 4.10
Thamani ya kampuni katika soko
577.84M CAD
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
TSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CAD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 88.08M | 1.70% |
Matumizi ya uendeshaji wa biashara | 40.40M | 3.49% |
Mapato halisi | 2.18M | 148.06% |
Kiwango cha faida halisi | 2.48 | 147.24% |
Mapato kwa kila hisa | 0.02 | 150.00% |
EBITDA | 6.05M | -60.32% |
Asilimia ya kodi ya mapato | 647.62% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CAD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 180.86M | -5.84% |
Jumla ya mali | 1.00B | 3.60% |
Jumla ya dhima | 207.60M | 0.62% |
Jumla ya hisa | 795.44M | — |
hisa zilizosalia | 99.63M | — |
Uwiano wa bei na thamani | 0.46 | — |
Faida inayotokana na mali | -1.41% | — |
Faida inayotokana mtaji | -1.63% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CAD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 2.18M | 148.06% |
Pesa kutokana na shughuli | 3.67M | -88.12% |
Pesa kutokana na uwekezaji | 32.13M | 231.85% |
Pesa kutokana na ufadhili | -4.70M | -62.20% |
Mabadiliko halisi ya pesa taslimu | 32.05M | 686.67% |
Mtiririko huru wa pesa | -7.56M | -883.33% |
Kuhusu
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Ilianzishwa
2014
Makao Makuu
Tovuti
Wafanyakazi
745
